Browse by Series:

FDA Approvals in Bladder Cancer and Hodgkin Lymphoma, Breakthrough Designation in AML, and More

Gina Columbus
Published: Thursday, May 26, 2016

SELECTED
LANGUAGE
Slider Left
Slider Right
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Atlanta: Advances in the Treatment of Chronic Lymphocytic LeukemiaFeb 28, 20190.5
Community Practice Connections™: 2nd Annual International Congress on Immunotherapies in Cancer™: Focus on Practice-Changing ApplicationFeb 28, 20192.0
Publication Bottom Border
Border Publication
x